Plastic Surgery Doctors in South Portland, ME Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

Ms. Therese K White, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 244 Western Avenue, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

Mr. David G Fitz, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 244 Western Ave, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

Mr. John A Attwood, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 244 Western Avenue, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

Mr. Thomas E Vaughan, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 244 Western Avenue, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

Dr. Sirish Maddali, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 244 Western Avenue, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

Mr. Richard C Flaherty, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 244 Western Avenue, South Portland, ME 04106 Phone: 207-775-3446    Fax: 207-879-1646

News Archive

Human organ chips for better drug development

The process of developing new drugs is both difficult and costly. It is estimated that of all the drug candidates which start out on their testing journey, less than 14% actually make it to the clinical scene and receive approval by the US Food and Drug Administration (FDA).

Child's IQ can be affected by mother's exposure to urban air pollutants

A mother's exposure to urban air pollutants known as polycyclic aromatic hydrocarbons (PAHs) can adversely affect a child's intelligence quotient or IQ, a study reports. PAHs are chemicals released into the air from the burning of coal, diesel, oil and gas, or other organic substances such as tobacco. In urban areas motor vehicles are a major source of PAHs.

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B16 model of metastases," published in "Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma" by Pérez-Lorenzo, et al. which reported that here, the authors showed that removing immune suppression and enhancing stimulatory signals increased the anti-tumor activity of unmodified TA99 antibodies with a significant reduction of growth of solid tumors and lung metastases in mouse models of melanoma.

CSIRO to produce antibodies for development of new vaccines against rotavirus

CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhoea in young children worldwide.

Read more Medical News

› Verified 2 days ago